Search results
4 days ago · FRIDAY, May 24, 2024 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel on Thursday recommended the approval of a new blood test that can spot colon cancer. The panel voted 7-2 ...
5 days ago · CRC occurs in about 150,000 patients in the U.S. annually and is the second-leading cause of cancer fatalities in the country with more than 50,000 deaths each year, according to the FDA.
4 days ago · In clinical trial data, published in The New England Journal of Medicine, Shield was found to have a 83.1% sensitivity rate, meaning 91% of patients with colorectal cancer detected by a ...
4 days ago · May 23, 2024, 2:47 PM PDT. By Reuters. Advisers to the U.S. Food and Drug Administration on Thursday recommended for the approval of Guardant Health’s blood test to detect a cancer that begins ...
4 days ago · Novo plans to seek FDA approval to expand Ozempic’s usage to treat chronic kidney disease. Wegovy, Novo’s obesity-focused GLP-1 counterpart, recently won approval for cardiovascular risk ...
4 days ago · Cancer is a disease of abnormal cell growth with the potential to spread to other parts of the body. Affecting millions of people around the world, there are many different types of cancer, each with unique characteristics and treatment options. Some of the most pressing cancer issues include access to affordable care, reducing health disparities, and improving cancer prevention and early ...
3 days ago · David Kessler, DO. David Kessler, DO is a Dermatologist in Massapequa, NY. They attended medical school at New York College Of Osteopathic Medical Of New York Inst Of Tech in 1986. They completed their residency at North Shore University Hospital. Their office is located in 70 Grand Ave, Massapequa, NY.
